GLP-1 and supplements

Nutrition guidance and a recruiting trial answer different questions. NCT07625202 tests creatine with resistance training during GLP-1 therapy; its estimated enrollment is not a completed-study sample. No personalised supplement dose or treatment stack is calculated.

• Joint nutrition advisory for GLP-1 therapy, 2025
• ClinicalTrials.gov: NCT07625202
• FDA: biotin interference with laboratory tests
• FDA: substance-specific compounding safety notes
• NAD interventions review, 2026 · PMID 41655607